K810626 is an FDA 510(k) clearance for the ELA MEDICAL PACING LEAD MODEL PMA 860.
Submitted by Ela Medical, Inc. (Mchenry, US). The FDA issued a Cleared decision on March 9, 1981.
This device falls under the Cardiovascular FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.
| 510(k) Number | K810626 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Product Development Protocol (SESP) |
| Date Received | March 09, 1981 |
| Decision Date | March 09, 1981 |
| Days to Decision | - |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | - |
| Third-party Review | No - reviewed directly by FDA |
| Product Code | - |
| Device Class | - |
Additional regulatory intelligence related to this FDA 510(k) submission, including predicate strategy, review pathways and device classification guidance.